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Abstract
Background: Recent evidence suggests that sodium imbalances may be associated with cognitive impairment;
however, the association between specific domains of cognition remains unclear. This study examines the
association between serum sodium levels and immediate and delayed verbal memory as measured by the CERAD
Word Learning Test (CERAD WLT), executive function as measured by the Animal Fluency test (AFT), and sustained
attention, working memory, and processing speed as measured by the Digit Symbol Substitution test (DSST) in the
elderly population of the US aged 60 and older who participated in the 2011–2014 National Health and Nutrition
Examination Surveys (n = 2,541).
Methods: Cognitive function tests were performed by trained interviewers and sodium levels were measured using
indirect ion selective electrode methodology.
Results: After adjusting for all covariates, quintiles of CERAD WLT scores showed significant positive associations
with log-transformed sodium levels (Immediate recall (IR) β = 4.25 (SE = 1.83, p-value 0.027); Delayed recall (DR) β =
6.54 (SE = 1.82, p-value 0.001)). Compared to normal sodium levels, hyponatremia was significantly associated with
lower CERAD WLT-IR (β = -0.34, SE = 0.15, p-value 0.035) and CERAD WLT-DR scores (β -0.48, SE = 0.10, p-value <
0.001) and showed borderline significance with AFT scores (β = = -0.38, SE = 0.19, p-value 0.052). Hypernatremia did
not show any significant relationships with cognitive test scores, compared to normal sodium levels.
Conclusions: Our cross-sectional study showed that lower sodium levels were associated with cognitive change,
especially regarding memory and executive function.
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Background
Sodium is one of the major extra-cellular fluid electro-
lytes, which is important in maintaining extracellular
fluid volume and potentials across cell membranes [1,
2]. Imbalances in sodium concentrations have been
known to manifest as headaches, confusion, nausea, and
restlessness, while rapid changes in sodium concentra-
tions result in acute neurologic symptoms such as sei-
zures and impaired mental status [2, 3]. Hyponatremia is
commonly defined as serum sodium concentrations less
than 135 mmol/L and is prevalent in the elderly due to
impaired water-excretory capacity associated with nor-
mal aging [1, 4]. Most cases of hyponatremia are mild
and relatively asymptomatic; however, recent evidence
suggests that hyponatremia may be associated with gait
disturbances, falls, and cognitive impairment [4–8].
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Only a few studies have addressed the relationship
between serum sodium levels and cognitive function;
however, the definition of cognitive function appears to
vary among studies. In addition, studies only examine
single domains of cognitive function, or assess multiple
domains grouped as a single variable. Previous studies
addressing the relationship between serum sodium
levels and cognitive function have assessed cognitive
function using a combination of attention tests (Visual
Vigilance, Working Memory or Digit Span, Go/No Go,
Intermodal Comparison, Divided Attention, Phasic
Alert tests) [7], the Audio Recorded Cognitive Screening
(ARCS) tool [8], a combination of the modified Mini-
Mental Status Exam (MMSE) and the Trail Making Test
[9], and a combination of the MMSE and Clock Comple-
tion Test [5]. In addition, most previous studies are lim-
ited to specific populations (i.e. men or single hospital
settings) [5, 7, 9].
Cognitive change is part of the normal process of
aging [10]. In contrast to cognitive domains such as lan-
guage, some cognitive abilities such as memory, execu-
tive function, and processing speed decline over time,
and the rate of decline varies among individuals [10, 11].
Cognitive performance is usually categorized in terms of
domains of functioning (i.e. executive functioning, pro-
cessing speed), and these domains are linked to specific
areas of the brain [12, 13]. In order to differentiate be-
tween the various types of conditions causing cognitive
impairment, specific subdomains are assessed separately
[13]. As a result, it is of importance to determine the
specific domains of cognitive function associated with
serum sodium levels. Our study aims to assess the
relationship between serum sodium levels and various
domains of cognitive function including, memory, ex-
ecutive function, and processing speed using the CERAD
Word Learning Test (CERAD WLT), Animal Fluency
test (AFT), and the Digit Symbol Substitution test




The National Health and Nutrition Examination Survey
(NHANES) is a major program of the National Center
for Health Statistics, part of the Centers for Disease
Control and Prevention. The survey is designed to com-
pile information on the health and nutritional status of
adults and children in the US. The NHANES conducts
interviews for demographic, socioeconomic, dietary, and
health-related questions and physical examinations for
medical, dental, and physiological measurements, as well
as laboratory tests. The survey is administered by highly
trained medical personnel [14].
We used the 2011–2012 and 2013–2014 National
Health and Nutrition Examination Surveys (NHANES),
which is a nationally representative sample of the non-
institutionalized population institutionalized population
in the US [14]. This study included a total of 19,931 in-
dividuals with data on serum sodium levels and cogni-
tive test scores. All study participants aged 60 years and
older (n = 3,632), who consented to the mobile examin-
ation center exam (n = 3,472), did not need a proxy in-
formant and read and understood English, Spanish,
Korean, Vietnamese, traditional or simplified Mandarin,
or Cantonese were eligible for cognitive function testing
(n = 3,398) [15, 16]. Among a total of 3,398 participants
eligible for testing, CERAD WLT-IR was conducted in 3,
131 individuals. Among these subjects, serum sodium
levels were measured in 2,946 participants, and 2,541
participants had data for all covariates.
Cognitive tests
The NHANES cognitive functioning questionnaire in-
cluded the CERAD WLT, AFT, and DSST. The CERAD
WLT evaluates immediate and delayed verbal memory.
The test is composed of three consecutive learning trials,
followed by a delayed recall test. Each learning trial is
followed by an immediate recall test. In the learning tri-
als, participants were presented with 10 words. Immedi-
ately following the learning trial, participants were
instructed to recall as many words as possible. The num-
ber of words correctly recalled was recorded as the score
for each learning trial, with a maximum possible score
of 10. This process was repeated three times, and the
final score for the CERAD WLT-IR was recorded as the
sum of scores from the three trials. The delayed recall
test was conducted after conducting the AFT and DSST
(approximately 8–10 min after starting the CERAD
WLT). Participants were asked to recall as many words
as possible, and scores were recorded as a number out
of 10. The AFT assesses executive function. Participants
were instructed to name as many animals as possible in
one minute, and the number of animals named was re-
corded as the score. Individuals who did not pass the
practice test, naming three articles of clothing, did not
participate in the AFT. The DSST examines sustained
attention, working memory, and processing speed. The
test consists of a paper form that has a legend at the top
in which 9 numbers are matched with 9 symbols. Partic-
ipants were given 133 numbers and were asked to copy
the corresponding symbol presented in the legend. The
total number of correct matches copied within 2 min
was recorded as the score out of 133 [15, 16].
Measurements of serum sodium levels
Blood samples were collected by a phlebotomist at the
NHANES Mobile Examination Centers [17, 18].
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Specimens were stored at appropriate refrigerated condi-
tions (2–8 degrees Celsius) before being shipped to the
Collaborative Laboratory Services, Ottumwa, Iowa for
analysis. Sodium levels were measured using the DxC800
system using indirect ion selective electrode methodology.
The DxC800 measures sodium levels using the voltage
created by sodium ion exchange [19, 20].
Other variables of interest
Other variables of interest included socio-demographic
factors and health behaviors and conditions. Socio-
demographic factors were age, sex, ethnicity (non-Hispanic
white, non-Hispanic black, Hispanic, or other), annual
household income (≤$20,000 or ≥$20,000), educational
levels (less than high school, high school graduate, or more
than high school), and marital status (married, never mar-
ried, widowed, divorced, separated, or living with partner).
Heath behavior variables included cigarette smoking status
(never smoker, former smokers, or current smoker), alcohol
consumption (yes or no), and moderate-intensity physical
activity status (yes or no). Health conditions were referred
to as body mass index, clinical examination, diuretic pre-
scription, and medical history. BMI was calculated using
person’s weight and height and categorized into four cat-
egories: underweight (< 18.5 kg/m2), normal weight (18.5–
24.9 kg/m2), overweight (25.0–29.9 kg/m2), and obese (>
30 kg/m2). Clinical examination related variables were
glomerular filtration rate (GFR) (ml/min per 1.73 m2) and
serum glucose levels (mg/dL). GFR was calculate using the
Chronic Kidney Disease Epidemiology Collaboration equa-
tion (CKD-EPI eGFR) [21]. Data on a history of cardiovas-
cular disease (defined as a history of coronary heart disease,
angina, or heart failure), diabetes, chronic pulmonary ob-
structive disease (COPD), thyroid disease, stroke, and liver
disease was also included.
Statistical analysis
Serum sodium levels were right–skewed and log trans-
formed. Log-transformed serum sodium levels were ana-
lyzed as both continuous and categorical variables by
hyponatremia, normonatremia, and hypernatremia sta-
tus. Serum sodium below 135 mmol/L was classified as
hyponatremia, and serum sodium above 145 mmol/L
was classified as hypernatremia [1]. Cognitive tests
scores were analyzed as quintiles because scores were
not normally distributed. Correlation analysis was per-
formed using Pearson’s correlation coefficients between
cognitive test scores and serum sodium levels were cal-
culated. Linear regression analysis was performed to de-
termine the relationship between serum sodium levels
and cognitive test scores. Beta coefficients and standard
errors (SE) for cognitive test scores among individuals
with hyponatremia and hypernatremia compared to
those with the normal serum sodium levels as the
reference group. The linear regression model was ad-
justed for all potential confounders including age, sex,
race, income, education, marital status, smoking history,
alcohol consumption, physical activity, BMI, GFR, serum
glucose, diuretic use, and a history of cardiovascular dis-
ease, diabetes, COPD, thyroid disease, stroke, and liver
disease.
All analyses were estimated by survey weight applied
to complex sampling design [22] performed with the
PROC SURVEY procedures of SAS 9.4 statistical analysis
package (SAS Institute, Cary, NC, USA). A significant
level was considered as α = 0.05.
Results
The characteristics of the study population with data for
CERAD WLT-IR (n = 2,541) are shown in Table 1. The
mean age of participants was 69.6 (± 6.8) years (range:
60–80), and women represented 51.4 % of the overall
sample. Most participants were non-Hispanic white
(49.3 %), not impoverished (74.8 %), had an education
beyond high school (51.0 %), and married (54.9 %). A
majority of the participants were overweight (35.4 %) or
obese (37.5 %). Mean CKD-EPI eGFR was 73.4 (± 19.8)
ml/min per 1.73 m2 and mean serum glucose was 112.4
(± 43.0) mg/dL.
Table 2 shows the distribution of participants among
cognitive function tests, and the means, medians and
Pearson correlation coefficients among log-transformed
sodium levels and cognitive test scores. The geometric
mean of log-transformed serum sodium was 4.938 (±
0.0008) mmol/L, and the median (interquartile range)
scores for the CERAD WLT-IR, CERAD WLT-DR, AFT,
and DSST were 19 (16-22), 6 (4-8), 16 (13-20), and 46
(34–59) respectively. Sodium showed positive correla-
tions with the test scores, and all correlations were sig-
nificant excluding the relationship between sodium and
AFT score, which showed borderline significance. Statis-
tically significant (p < 0.05) positive correlation coeffi-
cients were observed between all cognitive test scores.
Table 3 shows the results of linear regression analyses
between log-transformed serum sodium and quintiles of
cognitive test scores. CERAD WLT-IR and CERAD
WLT-DR showed significant positive associations with
log-transformed sodium levels in all models (CERAD
WLT-IR: unadjusted model: 5.35 (SE = 1.88, p-value
0.008), adjusted model: 4.25 (SE = 1.83, p-value 0.027);
CERAD WLT-DR: unadjusted model: 6.91 (SE = 1.95, p-
value 0.001), adjusted model: 6.54 (SE = 1.82, p-value
0.001)). Beta coefficients for the associations between
AFT and DSST scores, and sodium levels showed posi-
tive associations, but were not statistically significant.
Table 4 shows the associations between log-transformed
serum sodium levels and cognitive test scores by hypona-
tremia and hypernatremia status. Compared to normal
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sodium levels, hyponatremia was significantly associated
with lower cognitive test scores in the unadjusted model
(CERAD WLT-IR beta = -0.58, SE = 0.18, p-value 0.002;
CERAD WLT-DR beta = -0.69, SE = 0.15, p-value < 0.001;
AFT beta = -0.62, SE = 0.19, p-value 0.002; DSST beta =
-0.52, SE = 0.23, p-value 0.030). In the adjusted model,
hyponatremia was significantly associated with lower
CERAD WLT-IR (beta = -0.34, SE = 0.15, p-value 0.035)
and CERAD WLT-DR scores (beta = -0.48, SE = 0.10, p-
value < 0.001), and showed borderline significance with
AFT scores (beta = -0.38, SE = 0.19, p-value 0.052), com-
pared to normal sodium levels. In contrast, the hyperna-
tremia group did not show any significant relationships
with cognitive test scores, compared to the normal sodium
group.
Linear regression analysis of quintiles of cognitive
function among patients with normal sodium levels and
low sodium levels, did not show any significant linear re-
lationships, excluding the adjusted relationship between
log-transformed normal serum sodium levels and quin-
tiles of CERAD WLT-DR (beta = 5.61, SE= 3.03, p-value
0.074), which showed borderline significance, as shown
in Table 5.
Discussion
In a cross-sectional study of the United States popula-
tion sampled from the 2010–2011 and 2013–2014
NHANES, serum sodium levels were positively associ-
ated with cognitive test scores in the elderly. Log-
transformed serum sodium levels were significantly asso-
ciated with quintiles of CERAD WLT scores. In addition,
compared to normal sodium levels, hyponatremia was
associated with lower CERAD WLT (memory sub-
domain) and AFT (executive function) scores. In short,
serum sodium levels were significantly associated with
the memory sub-domain assessed by the CERAD WLT
and executive function assessed by the AFT, but not
with processing speed, sustained attention, and working
memory evaluated by the DSST.
In line with the results of our study, previous studies
have reported an association between low sodium levels
and cognitive function; however, these studies have only
Table 1 Characteristics of the study population
Characteristics Mean ± SD or N(%)
No of participants 2541
Sex
Male 1236 (48.6 %)
Female 1305 (51.4 %)
Age at interview (year) 69.6 ± 6.8
Ethnicity
Non-Hispanic white 1252 (49.3 %)
Non-Hispanic black 573 (22.6 %)
Hispanic 477 (18.8 %)
Others 239 (9.4 %)
Annual Family Income
Less than $20,000 640 (25.2 %)
$20,000 and over 1901 (74.8 %)
Education
Less than high school 645 (25.4 %)
High school graduate 600 (23.6 %)
More than high school 1296 (51.0 %)
Marital status
Married 1395 (54.9 %)
Never married 146 (5.8 %)
Widowed/divorced/separated 1000 (39.4 %)
Smoking history
Never smoked 329 (13.0 %)
Ex-Smoker 954 (37.5 %)
Current Smoker 1258 (49.5 %)
Alcohol consumptiona
Yes 1729 (68.0 %)
No 812 (32.0 %)
Physical Activityb
Yes 985 (38.8 %)
No 1556 (61.2 %)
BMI (kg/m2)
Underweight (< 18.5) 35 (1.4 %)
Normal weight (18.5–24.9) 653 (25.7 %)
Overweight (25.0-29.9) 899 (35.4 %)
Obesity (> 30) 954 (37.5 %)
CKD-EPI eGFR, ml/min per 1.73 m2 73.4 ± 19.8
Serum glucose, mg/dL 112.4 ± 43.0
Diuretic use 478 (18.8 %)
Diabetes 617 (24.3 %)
Cardiovascular diseasec 383 (15.1 %)
Stroke 173 (6.8 %)
Table 1 Characteristics of the study population (Continued)
Characteristics Mean ± SD or N(%)
Chronic obstructive pulmonary disease 242 (9.5 %)
Thyroid disease 434 (17.1 %)
Liver disease 143 (5.6 %)
a Response to the question: “In any one year, have you had at least 12 drinks
of any type of alcoholic beverage?”
b Response to the question: “In a typical week do you do any moderate-
intensity sports, fitness, or recreational activities that cause a small increase in
breathing or heart rate such as brisk walking, bicycling, swimming, or
volleyball for at least 10 minutes continuously?”
c Defined as a history of heart failure, coronary heart disease, or angina
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examined single domains of cognitive function (i.e.
attention), or have assessed multiple domains grouped
as a single variable. A case-control study performed in a
general hospital in Brussels reported that individuals
with low serum sodium levels (n = 122, range: 115–132
mmol/L, mean ± standard deviation [SD] = 126 ± 5
mmol/L) were associated with a higher odds of falling
(odds ratio [OR] = 67.43, 95 % confidence interval [CI] =
7.48–607.42) and significantly slower mean response
times in the attention tests (difference: 58 milliseconds,
P < 0.001) compared to individuals with normal sodium
levels (n = 244, mean ± SD = 139 ± 2 mmol/L) [7]. Eight
different visual and auditory attention tests were in-
cluded in the battery of attentional tests [7]. A cross-
sectional study from the Hunter Community Study, a
population-based prospective cohort study in Australia,
revealed that standardized ARCS scores were signifi-
cantly higher (mean = 4.67 units, 95 % CI = 1.56–7.79,
p = 0.01) for subjects with serum sodium levels equal to
135 mmol/L than those with serum sodium levels of 130
mmol/L [8]. The ARCS scores is a vague tool which re-
flects a wide range of cognitive domains [23]. A recent
study from the Osteoporotic Fractures in Men study, re-
vealed that men with sodium levels of 126–140 mmol/L
were associated with a 1.30 odds (95 % CI = 1.06–1.61)
of cognitive impairment, compared to individuals with
sodium levels of 141–142 mmol/L. In this study, cogni-
tive impairment was defined as a modified Mini-Mental
Status score less than 84 or a Trail Making Test Part B
time greater than 233 s [9]. In addition, a study con-
ducted in 150 patients aged 70 years and older from the
University Hospital Cologne, showed that resolution of
hyponatremia (< 130 mmol/L) by > 5 mmol/L was sig-
nificantly associated with an increase in MMSE scores
(ΔMMSE: 1.8 ± 3.0 vs. 0.7 ± 1.9; p = 0.002) [24]. Revers-
ibility has also been reported in previous animal studies
mentioned below [25, 26].
The mechanisms behind this association is unclear;
however, abnormalities in brain osmolyte levels such as
glutamate may play a role [6, 25, 26]. In chronic hypona-
tremia, brain cells export osmolytes such as glutamate,
which may influence memory [27, 28]. An animal study
showed that sustained low levels of serum sodium con-
centrations caused reversible cognitive impairment mea-
sured by a novel object recognition test and contextual
fear conditioning tests [26]. In vivo analysis of brain
samples from chronic hyponatremic rats in this study re-
vealed elevated extracellular glutamate concentrations in
the hippocampus and decreased glutamate uptake by
astrocyte cultures [26, 29]. In addition, another study in
rats proposed brain cell swelling as another explanation.
In this study, rats with chronic hyponatremia, which
showed reversible memory impairments assessed using
the passive avoidance test, also showed brain swelling
[25]. However, the reason why lower serum sodium
levels are associated with memory sub-domain and ex-
ecutive function, in contrast to sustained attention,
working memory, and processing speed, is unknown,
and further studies are recommended to clarify the
mechanism behind such association.
Our study has examined the relationship between
serum sodium levels and various cognitive domains in a






Pearson’s correlation coefficients (p-value)
Sodium,
mmol/L
CERAD WLT AFT score DSST
scoreIR score DR score
Sodium, mmol/L 4.938 (0.0008) 1.00
CERAD WLT-IR score 2541 19 (16–22) 0.10 (< 0.001) 1.00
CERAD WLT-DR score 2540 6 (4–8) 0.08 (< 0.001) 0.73 (< 0.001) 1.00
AFT score 2523 16 (13–20) 0.04 (0.068) 0.39 (< 0.001) 0.35 (< 0.001) 1.00
DSST score 2465 46 (34–59) 0.07 (0.001) 0.47 (< 0.001) 0.45 (< 0.001) 0.50 (< 0.001) 1.00
Table 3 Associations between log-transformed serum sodium levels and quintiles of cognitive test scores by linear regression
models
Model CERAD WLT-IR (n=2541) CERAD WLT-DR (n=2540) AFT (n=2523) DSST (n=2465)
Beta ± SE P Beta ± SE P Beta ± SE P Beta ± SE P
Unadjusted 5.35 ± 1.88 0.008 6.91 ± 1.95 0.001 2.35 ± 1.53 0.136 2.92 ± 1.88 0.129
Adjusteda 4.25 ± 1.83 0.027 6.54 ± 1.82 0.001 2.12 ± 1.39 0.135 1.59 ± 1.64 0.341
a Adjusted for sex, age, marital status, ethnicity, smoking status, alcohol consumption, physical activity, income, obesity, education, GFR, serum glucose levels,
diuretics use, diabetes, CVD, stroke, COPD, thyroid disease, and liver disease
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nation-wide population of US adults. Nevertheless, our
study has several limitations. Firstly, due to the cross-
sectional nature of the study, any casual or temporal re-
lationships cannot be assessed. Moreover, due to the
cross-sectional nature of the NHANES data, we were
unable to differentiate between acute and chronic hypo-
natremia. Despite this fact, it is more likely that the so-
dium status of most participants reflect chronic levels as
acute changes in sodium levels are known to cause
neurologic symptoms (i.e. seizures and altered mental
status) as a result of cerebral edema [3]. Thirdly, the re-
lationship between cognitive test scores and serum so-
dium levels may not necessarily be linear. Resultantly,
our results may not be generalized to populations with
different sodium levels. Fourthly, although we have con-
sidered basic sociodemographic variables, GFR, and
serum glucose levels as covariates, previous studies have
also included quality-of-life measures [7, 9]. Therefore,
we cannot completely eliminate the possibility of re-
sidual confounding. Fifthly, the range of cognitive test
scores performed by the NHANES remains limited, and
further studies evaluating the relationship between other
domains of cognitive function and serum sodium levels
are recommended. Additionally, among a total of 3,632
individuals aged 60 years and older who participated in
the 2011–2014 NHANES, only 2,541 for CERAD WLT-
IR, 2,540 for CERAD WLT-DR, 2,523 for AFT, and 2,
465 for DSST were included in the final analysis due to
various reasons (refusal, language/communication prob-
lems, failure to pass the practice test, need for a proxy,
time constrains, and missing data on serum sodium or
covariates). Because cognitive test scores were missing
for subjects who needed a proxy, did not pass the prac-
tice test, and quit or gave up, the overall study sample
may have included those with relatively higher cognitive
function scores, limiting the external validity of our re-
sults. Lastly, individuals with hypernatremia may have
shown no association due to the small sample sizes (<
10). Further studies should be conducted with larger
sample sizes to investigate the relationship between
hypernatremia and the separate domains of cognitive
function.
Conclusions
In conclusion, lower sodium levels were associated with
cognitive change, especially regarding memory and ex-
ecutive function in a population based study of US
Table 4 Linear regression analysis of log-transformed serum
sodium levels and quintiles of cognitive test scores by
hyponatremia and hypernatremia status
n Unadjusted model Adjusted modela
Beta ± SE P Beta ± SE P
CEARD WLT-IR
Normal 2446 1 1
Hyponatremia 87 -0.58 ± 0.18 0.002 -0.34 ± 0.15 0.035
Hypernatremia 8 0.39 ± 0.67 0.565 0.13 ± 0.68 0.852
CEARD WLT-DR
Normal 2445 1 1
Hyponatremia 87 -0.69 ± 0.15 <0.001 -0.48 ± 0.10 <0.001
Hypernatremia 8 0.60 ± 0.59 0.318 0.42 ± 0.62 0.496
AFT
Normal 2428 1 1
Hyponatremia 86 -0.62 ± 0.19 0.002 -0.38 ± 0.19 0.052
Hypernatremia 9 -0.63 ± 0.65 0.334 -0.69 ± 0.44 0.127
DSST
Normal 2376 Reference Reference
Hyponatremia 81 -0.52 ± 0.23 0.030 -0.18 ± 0.21 0.382
Hypernatremia 8 0.23 ± 0.47 0.620 0.07 ± 0.41 0.866
aAdjusted for sex, age, marital status, ethnicity, smoking status, alcohol
consumption, physical activity, income, obesity, education, GFR, serum glucose
levels, diuretics use, diabetes, CVD, stroke, COPD, thyroid disease, and
liver disease
Table 5 Linear regression analysis of log transformed serum sodium levels and quintiles of cognitive test scores stratified by serum
sodium levels
Model CERAD WLT-IR CERAD WLT-DR AFT DSST
Beta ± SE P Beta ± SE P Beta ± SE P Beta ± SE P
Hyponatremia (<135 mmol/L)
n 87 87 86 81
Unadjusted 5.36 ± 12.62 0.674 3.17 ± 12.43 0.800 3.57 ± 11.78 0.764 9.84 ± 10.99 0.379
Model 1a 17.51 ± 12.67 0.179 15.96 ± 11.08 0.162 -1.39 ± 8.56 0.873 2.74 ± 10.12 0.789
Normal serum sodium (135-145 mmol/L)
n 2446 2445 2428 2376
Unadjusted 2.50 ± 3.04 0.418 4.35 ± 3.06 0.164 -1.20 ± 2.08 0.569 -1.03 ± 2.13 0.632
Model 1a 3.16 ± 2.80 0.267 5.61 ± 3.03 0.074 1.08 ± 2.19 0.625 0.22 ± 1.75 0.900
a Adjusted for sex, age, marital status, ethnicity, smoking status, alcohol consumption, physical activity, income, obesity, education, GFR, serum glucose levels,
diabetes, CVD, COPD, thyroid disease, and liver disease
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adults aged 60 and over, pointing to hyponatremia as a
risk factor of cognitive impairment. When evaluating
memory and executive function in the elderly, serum so-
dium levels should be taken into account, as they may
cause reversible changes in cognitive function. In
addition, further studies should be conducted in order to
elucidate the mechanism behind such relationships.
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